NCT04645407View on ClinicalTrials.gov

Effects of Fuzheng Huayu Tablets on COVID-19

PHASE4CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

April 15, 2020

Study Completion Date

April 15, 2020

Conditions
Novel Coronavirus Pneumonia
Interventions
DRUG

Fuzheng Huayu tablet

Fuzheng Huayu tablet (0.4g/tablet, 1.6g/time, 3 times/day, oral; take medicine after meals each time)

Trial Locations (1)

201203

Shuguang Hospital, Shanghai

All Listed Sponsors
collaborator

Hubei Hospital of Traditional Chinese Medicine

OTHER

collaborator

Jingmen No.1 People's Hospital

OTHER

lead

ShuGuang Hospital

OTHER

NCT04645407 - Effects of Fuzheng Huayu Tablets on COVID-19 | Biotech Hunter | Biotech Hunter